![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
Advertisement
All
>
Persons > Northern Europe
Please find below persons from Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden and the UK as well as related to organisations from these countries.Total search results: 4158 | Ordered by Person (ascending)
1 2 3 ... 40 41 42
  Person |
 Position |
Organisation (Group) |
Country |
|---|---|---|---|
| Wright, Robin (MiNA Therapeutics 202101– CFO before Pharming + Karolinska Development + Orexo + Citibank) | Chief Financial Officer (CFO) | MiNA Therapeutics Ltd. | United Kingdom (GB) |
| Wright, Will (Evaxion Biotech 201604 Head of Business Development) | Business Development Manager / Strategy Manager | Evaxion Biotech A/S (Nasdaq: EVAX) | Denmark |
| Wrighton-Smith, Peter (Oxford Immunotec 200508 CEO) | Chief Executive Officer (CEO) | Oxford Immunotec (Group) | United Kingdom (GB) |
| Wuite, Frans (Acesion Pharma 201604– CEO before Oncos Therapeutics + Amgen + Warren & Araim Pharma) | Chief Executive Officer (CEO) | Acesion Pharma ApS | Denmark |
| Wulff, Henrik (Novo Group 202112 EVP Product Supply, Quality + IT at Novo Nordisk) | President/Director/Head Business Group/Unit/Division | Novo Group (Group) | Denmark |
| Wulff, Peter (Bavarian Nordic 200507–200707 CEO afterward VP BusDev) | Business Development Manager / Strategy Manager | Bavarian Nordic (Group) | Denmark |
| Wyatt, Mark (Swansea Univ 200208–200910– Research Officer EPSCR NMSSC) | Researcher (university / research institute) | Swansea University | United Kingdom (GB) |
| Wykeman, Nick (Allergy Therapeutics 201709 Finance Director) | Chief Financial Officer (CFO) | Allergy Therapeutics (Group) | United Kingdom (GB) |
| Wylie, Paul (TTP LabTech 200801 Senior Commercial Scientist) | n. a. | SPT Labtech (Group) | United Kingdom (GB) |
| Würtz, Jan (Gyros 200407– CEO) | Chief Executive Officer (CEO) | Mesa Laboratories (Mesa Labs) (Group) | Sweden |
| Xu, Joanne (SoftBank 202106 Partner at SoftBank Investment Advisers + 202106– Board Director at Exscientia) | Partner (venture partner) | SoftBank (Group) | |
| Yachi, Toshiyuki (Biotage 201209 VP Marketing) | Sales Manager / Marketing Manager | Biotage (Group) | Sweden |
| Yadi, Hakim A. (Closed Loop Medicine 202203 CEO + Co-Founder) | Chief Executive Officer (CEO) | Closed Loop Medicine Ltd. | United Kingdom (GB) |
| Yakneen, Sergei (Alphabet 202205– CTO at Isomorphic Labs before Sophia Genetics + Amazon + BPS) | Chief Technology/Technical Officer (CTO) | Alphabet (formerly Google) (Group) | United Kingdom (GB) |
| Yarkoni, Orr (Colorfix 202211 CEO Co-Founder) | Chief Executive Officer (CEO) | Colorifix Ltd. | United Kingdom (GB) |
| Yates, Chris (Abingdon Health 201710 CEO) | Chief Executive Officer (CEO) | Abingdon Health (Group) | United Kingdom (GB) |
| Yeadon, Mike (Ziarco Pharma 201211– CEO + founder before Pfizer Research UK) | Chief Executive Officer (CEO) | Novartis (Group) | United Kingdom (GB) |
| Yeatman, Eric (Microsaic Systems 201307– Non-exeuctive Director before Chairman + acting CEO) | Board member, non-executive | Microsaic Systems plc (AIM: MSYS) | United Kingdom (GB) |
| Yeatman, Graham (Retroscreen Virology 201307 Financial Director) | Chief Financial Officer (CFO) | Retroscreen Virology (Group) | United Kingdom (GB) |
| Yemm, Stephen (Steve) (Optibrium 202301– Chief Commercial Officer before Paradigm4 + Aigenpulse + BioData + Vialis) | Chief Commercial Officer (CCO) | Optibrium (Group) | United Kingdom (GB) |
| Yeo, Marcus (Definigen Ltd 201406 CEO) | Chief Executive Officer (CEO) | DefiniGen Ltd. | United Kingdom (GB) |
| Young, Alethia (Bicycle Therapeutics 202307– CFO before Graphite Bio + Cantor Fitzgerald + Credit Suisse + Dt Bank) | Chief Financial Officer (CFO) | Bicycle Therapeutics (Group) | United Kingdom (GB) |
| Young, Malcolm (e-Therapeutics 2007–201607 CEO founded e-Therapeutics 2003 STEPPED DOWN 7/16) | Chief Executive Officer (CEO) | e-Therapeutics plc (AIM: ETX) | United Kingdom (GB) |
| Young, Michael (Lindus Health 202308 Co-Founder) | Company Founder | Lindus Health Ltd. | United Kingdom (GB) |
| Young, Rachael (BioStrata 202404 Senior Account Manager) | Public Relations Manager / Investor Relations Manager | BioStrata Ltd. (Biostrata Marketing) | United Kingdom (GB) |
| Young, Sharon (Strategic Scientific 200902 Director) | President/Director/Head Business Group/Unit/Division | Stratech Scientific Ltd. | United Kingdom (GB) |
| Young, Steve (Sygnature Discovery 202204 VP of Business Development) | Business Development Manager / Strategy Manager | Sygnature Discovery (Group) | United Kingdom (GB) |
| Yrvum, Tone (Mole Genetics 200705 VP Marketing) | Sales Manager / Marketing Manager | Mole Genetics AS | Norway |
| Yver, Antoine (AstraZeneca 201309 VP + Head of Oncology in Global Medicines Development Unit) | President/Director/Head Business Group/Unit/Division | AstraZeneca (Group) | United Kingdom (GB) |
| Zaccagnini, Kiki (Instinctif Partners 202007) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | United Kingdom (GB) |
| Zacho, Helle (Dutscher 202304– CEO of AH Diagnostics joined as CSO in 2017 before Novo Nordisk) | Chief Executive Officer (CEO) | Dutscher (DD) (Group) | Denmark |
| Zafirakos, Elias (BioPeople (DK) 201404 Science Liaison Officer) | Cluster Manager | Biopeople (Denmark’s Life Science Cluster) | Denmark |
| Zajicek, George (Axis-Shield –200512–200804– BusDev Director before Unipath Ltd + Boehringer Ingelheim) | Business Development Manager / Strategy Manager | Abbott (Group) | United Kingdom (GB) |
| Zang, Jingwu (I-Mab 201711 CEO + Founder of I-Mab Biopharma before GSK RnD China 200705 Head) | Chief Executive Officer (CEO) | GSK (Group) | United Kingdom (GB) |
| Zeilemaker, Sijme (Immunicum 201703– Director Business Development before InteRNA Technologies + to-BBB Technologies) | Business Development Manager / Strategy Manager | Mendus (Group) | Sweden |
| Zerhouni, Peter (InDex Pharmaceuticals 201610 CEO) | Chief Executive Officer (CEO) | InDex Pharmaceuticals (Group) | Sweden |
| Zheng, Ran (Landmark Bio 202107– CEO before Orchard Therapeutics + Amgen + Diosynth + Genzyme) | Chief Technology/Technical Officer (CTO) | Landmark Bio PBLLC | United States (USA) |
| Zhou, Jason (China Resources Group 202008 CEO + Managing Director of CR-CP Life Science Fund) | Chief Executive Officer (CEO) | China Resources Group (Group) | China |
| Zhou, Tingting (Novogene 202312 VP of Novogene Europe) | President/Director/Head Business Group/Unit/Division | Novogene (Group) | United Kingdom (GB) |
| Zipkin, Mark (IB Communicsion 202212) | Public Relations Manager / Investor Relations Manager | Image Box Ltd. (Image Box PR / IB Communications) | United Kingdom (GB) |
| Zocca, Mai-Britt (IO Biotech ApS 201601 CEO + Founder) | Chief Executive Officer (CEO) | IO Biotech (Group) | Denmark |
| Zocco, Giuseppe (Medicxi 201706 Partner before Index Ventures Co-Founder) | Partner (venture partner) | Medicxi Ventures (formerly Index Ventures Life Sciences) | United Kingdom (GB) |
| Zohar, Daphne (Seaport Therapeutics 202404– CEO + Co-Founder before PureTech Health CEO + Co-Founder) | Chief Executive Officer (CEO) | Seaport Therapeutics (US) | United States (USA) |
| Zook, Tony (AstraZeneca –201301 EVP Global Commercial LEFT 1/13 before CEO of AstraZeneca USA) | President/Director/Head Business Group/Unit/Division | AstraZeneca (Group) | United Kingdom (GB) |
| Zou, Johnny (Primavera Capital 202109 at Primavera Venture Partners) | Investment Manager | Primavera Capital (Group) | China |
| Zubarev, Roman A. (Karolinska Instutet 201005 Professor before Univ Uppsala 200712 Professor) | Professor | Karolinska Institutet | Sweden |
| Åberg, Anders (Sprint Bioscience 2009–201906 CEO + Co-Founder RESIGNED 6/19) | Chief Executive Officer (CEO) | Sprint Bioscience AB | Sweden |
| Åmark, Martin (Xbrane 2020 CEO9 | Chief Executive Officer (CEO) | Xbrane (Group) | Sweden |
| Åström, Håkan | Board member | Affibody Medical AB | Sweden |
| Öhman, Lars (Immunscape 201609 CEO) | Chief Executive Officer (CEO) | Immunscape AB | Sweden |
| Öhman, Ove (Åmic 200806 CEO + founder) | Chief Executive Officer (CEO) | Johnson & Johnson (JnJ) (Group) | Sweden |
| Öhrn, Iris (Business Region Göteborg 201211 Investment Manager Life Sciences) | Cluster Manager | Göteborg Bio – Business Region Göteborg AB | Sweden |
| Šakalys, Vidmantas (Vital 3D technologies 202403 CEO + Co-Founder) | Chief Executive Officer (CEO) | Vital 3D Technoloiges (Vital3D) (LT) | Lithuania |
| Žunda, Giedrius (Northway 201812– CEO of Biotechpharma UAB before Sicor Biotech UAB/Teva since 2002) | Chief Executive Officer (CEO) | Northway (Group) | Lithuania |
| Ørnskov, Flemming (Shire 201301– CEO before Bayer Chief Marketing Officer + Bausch & Lomb + Ikaria + Novartis) | Chief Executive Officer (CEO) | Takeda (Group) | Ireland, Republic of |
| Ørum, Henrik (Santaris Pharma 200712 CSO + VP BusDev) | Business Development Manager / Strategy Manager | Roche (Group) | Denmark |
| Østergaard, Jes (DakoCytomation 200506 CEO) | Chief Executive Officer (CEO) | Agilent (Group) | Denmark |
| Øystein, Soug (Polaris 201506 announced as CFO before Algeta + Orcla) | Chief Financial Officer (CFO) | Polaris (NO) (Group) | Norway |
1 2 3 ... 40 41 42
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
